A evolução da insulinoterapia no diabetes melito tipo 1

0Citations
Citations of this article
139Readers
Mendeley users who have this article in their library.

Abstract

The discovery of insulin can be considered the milestone of diabetes mellitus history and a great achievement for its treatment. The first insulin available was the regular. Afterwards, Hagedorn added the protamine to the insulin, thus, creating the NPH insulin. In the 1950s an insulin free of protamine was synthesized: the lente insulin. With the advent of molecular biology, synthetic human insulin was synthesized using recombinant DNA technology. Most recently several types of insulin analogues were available, providing the patients with better metabolic control. Type 1 diabetes mellitus treatment includes plain substitution and individualization for short-acting plus long-acting insulin according to the physician's assistance, besides regular practice of physical activities and diet orientations. In type 1 diabetes mellitus the insulin of low variability is the best choice since basal/bolus insulin therapy or continuous subcutaneous insulin infusion pump can mimetize the physiological release of insulin by β cells. Copyright© ABE&M.

Cite

CITATION STYLE

APA

Pires, A. C., & Chacra, A. R. (2008, March). A evolução da insulinoterapia no diabetes melito tipo 1. Arquivos Brasileiros de Endocrinologia e Metabologia. https://doi.org/10.1590/S0004-27302008000200014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free